The ART Cohort Collaboration (ART-CC) was supported from 2018-2024 by the US National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant U01‐AA026209. 

The ART-CC is currently funded by the US National Institute of Allergy and Infectious Diseases (NIAID) grant R01-AI181733.

Sources of funding of individual cohorts include:

• The Agence nationale de recherches sur le SIDA et les hépatites virales (ANRS)
• The Institute National de la Santé et de la Recherche Médicale (INSERM)
• The French, Italian, and Spanish Ministries of Health
• The Swiss National Science Foundation (grant 33CS30_134277)
• The Ministry of Science and Innovation and the Spanish Network for AIDS Research (RIS; ISCIII-RETIC RD06/006)
• The Stichting HIV Monitoring
• The Alberta Government
• The National Institutes of Health (NIH)
• UW CFAR (NIH grant P30 AI027757) USA
• The Canadian Institutes of Health Research
• The VHA Office of Research

Development and unrestricted grants for individual cohorts include:

• GlaxoSmithKline
• Pfizer
• Bristol Myers Squibb
• Roche
• Boehringer-Ingelheim